The main objective of this study is investigating whether augmented reality can provoke symptoms in patients with contamination-based OCD by evaluating how this AR HMD symptom provocation compares to a traditional symptom provocation.
ID
Source
Brief title
Condition
- Anxiety disorders and symptoms
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
- AR HMD task, the main study parameters consist of self-reports measured by a
VAS and physiological recordings of heart rate and Skin Conductance level (SCL)
measured by the VU-AMS.
- Traditional Symptom Provocation task, the main study parameters consist of
self-reports measured by a VAS and physiological recordings of heart rate and
Skin Conductance level (SCL) measured by the VU-AMS.
Secondary outcome
N/A
Background summary
Traditional symptom provocations are an effective means for assessing symptoms.
In order to further optimize traditional symptom provocations, researchers have
recently proposed the use of virtual reality (VR) as a device that can be used
to present dynamic stimuli. Virtual reality can be defined as a stereoscopic,
computer-generated reality that enables an individual to experience all three
dimensions of a virtual scene from any perspective, i.e. the first or third
person perspective. In order to accomplish this, the participant wears a
headset, known as a head-mounted display (HMD), which displays content that
envelops their entire field of view. While this method is promising, there is a
significant and inherent caveat in this design. While remaining tethered to a
stationary desktop computer in order to conduct a symptom provocation,
clinicians will remain unable to comprehensively understand the manifestations
of these symptoms in real world settings. In order to circumvent these issues,
the present research proposes to introduce a novel approach, which can be
defined as stereoscopic augmented reality with a head-mounted display for
exposure based treatments. Augmented reality (AR) with a head-mounted display
enables an individual to experience stereoscopic computer generated images that
are overlaid into the viewer*s natural environment. The present study will
therefore seek to clinically validate the use of this technology as a tool for
being able to successfully elicit symptomatic responses in patients with
contamination-based OCD.
Study objective
The main objective of this study is investigating whether augmented reality can
provoke symptoms in patients with contamination-based OCD by evaluating how
this AR HMD symptom provocation compares to a traditional symptom provocation.
Study design
This is a pilot study with behavioral outcome measures.
Intervention
Augmented Reality exposure
Study burden and risks
The risk and burden associated with participation can be considered minimal.
There will be a total of 1 Traditional Symptom Provocation and 1 AR HMD symptom
provocation per individual, each of which takes ~1 hour to complete.
Furthermore, structured diagnostic interviews for psychiatric disorders and
personality questionnaires in addition to self-report questionnaires will be
administered.
Meibergdreef 5
Amsterdam 1105AZ
NL
Meibergdreef 5
Amsterdam 1105AZ
NL
Listed location countries
Age
Inclusion criteria
The recruitment of participants takes place as follows. Practitioners at the department of Psychiatry will inform OCD-patients currently being treated or are currently waitlisted for treatment within our institution about our study. If someone is willing to participate in the study, we will personally visit with them at the Psychiatry department to inform them of the entire procedure. Moreover, they will receive an information letter by email that reviews all of the information again in detail in order to ensure that they have the opportunity to fully understand the procedure. If they are still interested in participating, they will sign an informed consent and we will perform screening for inclusion and exclusion criteria. Demographics and clinician-related questionnaires (Y-BOCS, GAF, HAM-D, HAM-A. BABS) will be administered to make sure that the individual can participate. If a participant meets any of the exclusion criteria, then they are excluded from participating in this study.;Inclusion criteria for OCD group:
-Men and women.
-Age between 25-65.
-Recent DSM-V diagnosis (mild, moderate, and severe) of obsessive-compulsive disorder with a primary diagnosis of contamination fear.
-Currently in treatment or are waiting for treatment in the AMC department of Psychiatry
Exclusion criteria
Exclusion criteria for OCD participants:
- A primary DSM-V diagnosis for any disorder(s) besides contamination-based obsessive-compulsive disorder or other subtype of obsessive-compulsive disorder.
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL58465.018.18 |